Staff Members - Benha University
TELOMERASE ACTIVITY IN ACUTE LEUKEMIA
• 2017
Publication Information
Authors
AZZA ABO SENNA, *AMINA EL SHAKANKIRY, ABLA EL RABAT, ABED IBRAHIM ABD EL HAMID AND MAHA YOUSSEF
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
In the present study, we used telomeric repeat amplification protocol assay (TRAP) and an internal telomerase assay standard to detect and quantitate telomerase activity in blood samples obtained from normal (control) subjects and acute leukemia patients.
Telomerase activity was analyzed in 25 acute myeloid leukemia (AML) patients, and 25 acute lymphoblastic leukemia (ALL) patients and ranged from 1.7-171.3 RTA (mean 42.64±57.65) and 2.1-149 RTA (mean 40.73±39.55) respectively relative to the internal standard.
Compared to the age-matched normal levels of telomerase activity in the peripheral blood cells, we determined that 21/25 (84%) of AML patients and 23/25 (92%) of ALL patients had heterogeneously elevated telomerase activity. Acute leukemia patients with high/moderate telomerase activity (AML: n= 12; ALL: n= 16) showed high leucocytic counts and more frequent extramedullary involvement during the disease. In AML, the level of telomerase activity was also associated with French-American-British (F AB) subtypes; patients with AML-M3 had normal to low telomerase activity.
Telomerase activity was analyzed in 25 acute myeloid leukemia (AML) patients, and 25 acute lymphoblastic leukemia (ALL) patients and ranged from 1.7-171.3 RTA (mean 42.64±57.65) and 2.1-149 RTA (mean 40.73±39.55) respectively relative to the internal standard.
Compared to the age-matched normal levels of telomerase activity in the peripheral blood cells, we determined that 21/25 (84%) of AML patients and 23/25 (92%) of ALL patients had heterogeneously elevated telomerase activity. Acute leukemia patients with high/moderate telomerase activity (AML: n= 12; ALL: n= 16) showed high leucocytic counts and more frequent extramedullary involvement during the disease. In AML, the level of telomerase activity was also associated with French-American-British (F AB) subtypes; patients with AML-M3 had normal to low telomerase activity.